ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men

Share/Save/Bookmark

Chion, Chan K.N.K. and Doggen, Carine J.M. and Crawley, James T.B. and Lane, David A. and Rosendaal, Frits R. (2007) ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood, 109 (5). pp. 1998-2000. ISSN 0006-4971

[img]PDF
Restricted to UT campus only
: Request a copy
105Kb
Abstract:Von Willebrand factor (VWF) mediates the tethering/adhesion of platelets at sites of vascular injury. This function depends on its multimeric size, which is controlled by ADAMTS13. We measured plasma ADAMTS13 and VWF antigen levels by enzyme-linked immunosorbent assay (ELISA) in a large population-based case-control study (Study of Myocardial Infarctions Leiden [SMILE]), consisting of 560 men with a first myocardial infarction (MI) and 646 control subjects. Although ABO blood groups influenced VWF levels, they had no influence on ADAMTS13. Furthermore, there was no relationship between plasma ADAMTS13 and VWF levels. Similar to VWF, the estimated risk of MI was increased for every quartile of ADAMTS13 when compared to the lowest quartile (odds ratio, 1.5-1.6). If confirmed, the association of ADAMTS13 with MI may suggest an unexpected mechanistic action of ADAMTS13
Item Type:Article
Copyright:Copyright © 2011 by American Society of Hematology
Link to this item:http://purl.utwente.nl/publications/77868
Official URL:http://dx.doi.org/10.1182/blood-2006-07-038166
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page